Analyses of synovial tissues from arthritic and protected congenic rat strains reveal a new core set of genes associated with disease severity

被引:6
作者
Brenner, Max [1 ,2 ]
Laragione, Teresina [1 ,2 ]
Gulko, Percio S. [1 ,2 ,3 ]
机构
[1] Feinstein Inst Med Res, Ctr Genom & Human Genet, Lab Expt Rheumatol, Manhasset, NY 11030 USA
[2] Hofstra North Shore LIJ Sch Med, Hempstead, NY USA
[3] Elmezzi Grad Sch Mol Med, Manhasset, NY USA
基金
美国国家卫生研究院;
关键词
autoimmunity; synovitis; erosion; environment; innate; COLLAGEN-INDUCED ARTHRITIS; PRISTANE-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; HISTOCOMPATIBILITY COMPLEX; JOINT DAMAGE; TNF-ALPHA; AUTOIMMUNE ARTHRITIS; PANNUS FORMATION; MAJOR ARTHRITIS; FUSION PROTEIN;
D O I
10.1152/physiolgenomics.00108.2013
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Little is known about the genes regulating disease severity and joint damage in rheumatoid arthritis (RA). In the present study we analyzed the gene expression characteristics of synovial tissues from four different strains congenic for non-MHC loci that develop mild and nonerosive arthritis compared with severe and erosive DA rats. DA. F344(Cia3d), DA. F344(Cia5a), DA. ACI(Cia10), and DA. ACI(Cia25) rats developed mild arthritis compared with DA. We found 685 genes with significantly different expression between congenics and DA, independent of the specific congenic interval, suggesting that these genes represent a new nongenetic core group of mediators of arthritis severity. This core group includes genes not previously implicated or with unclear role in arthritis severity, such as Tnn, Clec4m, and Spond1 among others, increased in DA. The core genes also included Scd1, Selenbp1, and Slc7a10, increased in congenics. Genes implicated in nuclear receptor activity, xenobiotic and lipid metabolism were also increased in the congenics, correlating with protection. Several disease mediators were among the core genes reduced in congenics, including IL-6, IL-17, and Ccl2. Analyses of upstream regulators (genes, pathways, or chemicals) suggested reduced activation of Stat3 and TLR-related genes and chemicals in congenics. Additionally, cigarette smoking was among the upstream regulators activated in DA, while p53 was an upstream regulator activated in congenics. We observed congenic-specific differential expression and detection in each individual strain. In conclusion, this new nongenetically regulated core genes of disease severity or protection in arthritis should provide new insight into critical pathways and potential new environmental risk factor for arthritis.
引用
收藏
页码:1109 / 1122
页数:14
相关论文
共 51 条
[41]   Evaluation of the effect of losartan and methotrexate combined therapy in adjuvant-induced arthritis in rats [J].
Refaat, Rowaida ;
Salama, Mona ;
Meguid, Elham Abdel ;
El Sarha, Ashgan ;
Gowayed, Mennatallah .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 698 (1-3) :421-428
[42]   The toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis [J].
Sacre, Sandra M. ;
Andreakos, Evangelos ;
Kiriakidis, Serafim ;
Amjadi, Parisa ;
Lundberg, Anna ;
Giddins, Grey ;
Feldmann, Marc ;
Brennan, Fionula ;
Foxwell, Brian M. .
AMERICAN JOURNAL OF PATHOLOGY, 2007, 170 (02) :518-525
[43]   Tenascin-W is found in malignant mammary tumors, promotes alpha8 integrin-dependent motility and requires p38MAPK activity for BMP-2 and TNF-alpha induced expression in vitro [J].
Scherberich, A ;
Tucker, RP ;
Degen, M ;
Brown- Luedi, M ;
Andres, AC ;
Chiquet- Ehrismann, R .
ONCOGENE, 2005, 24 (09) :1525-1532
[44]   Cigarette smoking increases the risk of rheumatoid arthritis - Results from a nationwide study of disease-discordant twins [J].
Silman, AJ ;
Newman, J ;
MacGregor, AJ .
ARTHRITIS AND RHEUMATISM, 1996, 39 (05) :732-735
[45]  
Vingsbo C, 1996, AM J PATHOL, V149, P1675
[46]   AT(1) RECEPTOR CHARACTERISTICS OF ANGIOTENSIN ANALOG BINDING IN HUMAN SYNOVIUM [J].
WALSH, DA ;
SUZUKI, T ;
KNOCK, GA ;
BLAKE, DR ;
POLAK, JM ;
WHARTON, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (02) :435-442
[47]   A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate [J].
Weinblatt, ME ;
Kremer, JM ;
Bankhurst, AD ;
Bulpitt, KJ ;
Fleischmann, RM ;
Fox, RI ;
Jackson, CG ;
Lange, M ;
Burge, DJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (04) :253-259
[48]  
Wiesenberg I, 1998, MOL PHARMACOL, V53, P1131
[49]   Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis [J].
Wolfe, Frederick ;
Rasker, Johannes J. ;
Boers, Maarten ;
Wells, George A. ;
Michaud, Kaleb .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (06) :935-942
[50]   Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis [J].
Yamanishi, Y ;
Boyle, DL ;
Pinkoski, MJ ;
Mahboubi, A ;
Lin, T ;
Han, ZN ;
Zvaifler, NJ ;
Green, DR ;
Firestein, GS .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (01) :123-130